| Regency House Nursing And Rehabilitation Center | |
| 181 E Main St, Wallingford, Connecticut 06492 | |
| (203) 265-1661 | |
| Name | Regency House Nursing And Rehabilitation Center |
|---|---|
| Location | 181 E Main St, Wallingford, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 130 |
| Occupancy Rate | 77.77% |
| Medicare ID (CCN) | 075261 |
| Legal Business Name | Regency House Of Wallingford, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1528126232 |
| Organization Name | REGENCY HOUSE OF WALLINGFORD, INC. |
| Doing Business As | REGENCY HOUSE NURSING AND REHABILITATION CENTER |
| Address | 181 E Main St, Wallingford, CT 06492 |
| Phone Number | 203-265-1661 |
News Archive
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Medical device safety researchers are calling on the Food and Drug Administration to release hundreds of thousands of hidden injury and malfunction reports related to about 100 medical devices.
Researchers from Swansea University Medical School have joined up with five other centers from around the world to compile the biggest recorded collection of families with forms of epilepsy where genetics may play a part in the recurring feature of the condition.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
Researchers have uncovered a biological link between the protein whose mutation causes early-onset Alzheimer's disease (AD) and a gene variant linked to late-onset AD.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Medical device safety researchers are calling on the Food and Drug Administration to release hundreds of thousands of hidden injury and malfunction reports related to about 100 medical devices.
Researchers from Swansea University Medical School have joined up with five other centers from around the world to compile the biggest recorded collection of families with forms of epilepsy where genetics may play a part in the recurring feature of the condition.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
Researchers have uncovered a biological link between the protein whose mutation causes early-onset Alzheimer's disease (AD) and a gene variant linked to late-onset AD.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $21568 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.58 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.47 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.19 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.54 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.19 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.3 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.08 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 80.95 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.27 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 68.75 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.23 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.26 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.65 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.04 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.03 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 67.02 | 82.93 |
News Archive
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Medical device safety researchers are calling on the Food and Drug Administration to release hundreds of thousands of hidden injury and malfunction reports related to about 100 medical devices.
Researchers from Swansea University Medical School have joined up with five other centers from around the world to compile the biggest recorded collection of families with forms of epilepsy where genetics may play a part in the recurring feature of the condition.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
Researchers have uncovered a biological link between the protein whose mutation causes early-onset Alzheimer's disease (AD) and a gene variant linked to late-onset AD.
› Verified 4 days ago
Skyview Rehab And Nursing Location: 35 Marc Drive, Wallingford, Connecticut 06492 Phone: (203) 265-0981 | |
Masonicare Health Center Location: 22 Masonic Ave Po Box 70, Wallingford, Connecticut 06492 Phone: (203) 679-5900 | |
Quinnipiac Valley Center Location: 55 Kondracki Lane, Wallingford, Connecticut 06492 Phone: (203) 265-6771 | |
Regency House Nursing And Rehabilitation Center Location: 181 E Main St, Wallingford, Connecticut 06492 Phone: (203) 265-1661 |